Viemed (VMD) Form 4 Discloses RSU and Phantom Share Grants to Director

Rhea-AI Filing Summary

Timothy Smokoff, a director of Viemed Healthcare, Inc. (VMD), received equity awards in August 2025. The Form 4 shows grants and the resulting ownership changes: 15,732 restricted stock units (RSUs) were reported as acquired on 08/20/2025 and 15,029 RSUs plus 3,757 phantom share units were acquired on 08/19/2025. After the 08/20/2025 transaction the filing shows the reporting person beneficially owned 95,518 common shares. The RSUs granted vest on specified future dates, and each phantom share represents a right to receive the cash value of one common share at vesting.

Positive

• Director alignment with shareholders through equity grants: Reporting person received 15,732 RSUs (08/20/2025), 15,029 RSUs (08/19/2025), and 3,757 phantom share units (08/19/2025).
• Clear vesting schedules disclosed: RSUs and phantom units have specified vesting dates, for example RSUs granted 08/19/2025 vest on the first anniversary of the grant date.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received time-based equity awards that increase reported beneficial ownership but are subject to future vesting.

The Form 4 documents time-vesting compensation: 15,732 RSUs reported on 08/20/2025 and 15,029 RSUs plus 3,757 phantom share units reported on 08/19/2025. The filing reports total beneficial ownership of 95,518 common shares following the 08/20/2025 transaction. These are compensation-related grants rather than open-market purchases or dispositions. The RSUs and phantom units have zero exercise price and specific vesting schedules noted in the explanations, indicating they will convert or pay out only upon vesting.

Corporate Governance Expert

TL;DR: Routine director equity awards disclosed; documentation includes vesting schedules and signature by attorney-in-fact.

The filing identifies Timothy Smokoff as a director and discloses awards granted under equity plans: RSUs granted 08/19/2025 vesting on the first anniversary and RSUs granted 08/20/2024 vesting 08/20/2025. Phantom share units granted 08/19/2025 vest on the first anniversary. The Form 4 is signed by an attorney-in-fact on 08/20/2025, and the explanations specify that each RSU equals one common share while phantom shares pay cash value based on share price at vesting. This is a standard disclosure consistent with director compensation practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smokoff Timothy

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/20/2025		M		15,732	A	(1)	95,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/20/2025		M			15,732	(2)	(2)	Common Shares	15,732	$0	0	D
Restricted Stock Units	(1)	08/19/2025		A		15,029		(3)	08/19/2026	Common Shares	15,029	$0	15,029	D
Phantom Share Units	(4)	08/19/2025		A		3,757		(5)	08/19/2026	Common Shares	3,757	$0	3,757	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. On August 20, 2024, the reporting person was granted Restricted Stock Units which vest on August 20, 2025.

3. Restricted Stock Units (RSUs) granted to reporting person on August 19, 2025, which vest on the first anniversary of the grant date.

4. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

5. Represents an award granted on August 19, 2025 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did VMD director Timothy Smokoff receive in August 2025?

He received 15,732 RSUs on 08/20/2025, 15,029 RSUs on 08/19/2025, and 3,757 phantom share units on 08/19/2025.

How many VMD common shares did the reporting person beneficially own after the reported transaction?

The filing reports 95,518 common shares beneficially owned following the 08/20/2025 transaction.

When do the RSUs and phantom share units vest according to the Form 4?

RSUs granted 08/19/2025 and phantom shares granted 08/19/2025 vest on the first anniversary of the grant; RSUs granted 08/20/2024 vested on 08/20/2025.

What does each phantom share unit represent in this filing?

Each phantom share represents a right to receive the cash value of one share of the issuer's common shares determined by the share price on the vesting date.

Who signed the Form 4 for Timothy Smokoff?

The Form 4 is signed by Jesse Bergeron, Attorney-in-Fact, dated 08/20/2025.